Logs: Bennett Institute
The following is a list of all job requests run via OpenSAFELY by Bennett Institute users.
| Status | Project | Workspace | Request ID | Backend | Jobs | User | Started | View request |
|---|---|---|---|---|---|---|---|---|
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10231 | TPP | 1/1 | Linda Nab | 3 years, 9 months ago 14 July 2022 14:09:28 UTC | View, Job request 10231 |
| Succeeded | Antidepressant Learning Disability and Autism | antidepressant-prescribing-lda | 10228 | TPP | 1/1 | Christine Cunningham | 3 years, 9 months ago 14 July 2022 13:41:37 UTC | View, Job request 10228 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10227 | TPP | 1/1 | Linda Nab | 3 years, 9 months ago 14 July 2022 13:30:14 UTC | View, Job request 10227 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10226 | TPP | 1/1 | Linda Nab | 3 years, 9 months ago 14 July 2022 12:55:22 UTC | View, Job request 10226 |
| Succeeded | Covid-19 related death over time | covid-mortality-over-time-imd | 10221 | TPP | 5/5 | Linda Nab | 3 years, 9 months ago 14 July 2022 11:41:48 UTC | View, Job request 10221 |
| Succeeded | OpenSAFELY Interactive | opensafely-interactive | 10218 | TPP | 4/4 | OpenSAFELY Interactive | 3 years, 9 months ago 14 July 2022 10:30:57 UTC | View, Job request 10218 |
| Succeeded | Covid-19 related death over time | covid_mortality_over_time | 10210 | TPP | 17/17 | Linda Nab | 3 years, 9 months ago 13 July 2022 21:18:42 UTC | View, Job request 10210 |
| Succeeded | Covid-19 related death over time | covid-mortality-over-time-imd | 10197 | TPP | 9/9 | Linda Nab | 3 years, 9 months ago 13 July 2022 13:46:33 UTC | View, Job request 10197 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10196 | TPP | 7/7 | John Tazare | 3 years, 9 months ago 13 July 2022 13:32:51 UTC | View, Job request 10196 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10195 | TPP | 1/1 | John Tazare | 3 years, 9 months ago 13 July 2022 13:14:40 UTC | View, Job request 10195 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10189 | TPP | 7/7 | John Tazare | 3 years, 9 months ago 13 July 2022 10:48:13 UTC | View, Job request 10189 |
| Succeeded | OpenSAFELY Interactive | opensafely-interactive | 10186 | TPP | 4/4 | OpenSAFELY Interactive | 3 years, 9 months ago 13 July 2022 09:26:46 UTC | View, Job request 10186 |
| Succeeded | OpenSAFELY Interactive | opensafely-interactive | 10185 | TPP | 4/4 | OpenSAFELY Interactive | 3 years, 9 months ago 13 July 2022 09:26:17 UTC | View, Job request 10185 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10182 | TPP | 4/4 | John Tazare | 3 years, 9 months ago 13 July 2022 08:16:36 UTC | View, Job request 10182 |
| Succeeded | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10179 | TPP | 1/1 | Bang Zheng | 3 years, 9 months ago 12 July 2022 22:22:43 UTC | View, Job request 10179 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10178 | TPP | 0/1 | Bang Zheng | 3 years, 9 months ago 12 July 2022 22:00:23 UTC | View, Job request 10178 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10177 | TPP | 0/1 | Bang Zheng | 3 years, 9 months ago 12 July 2022 21:57:50 UTC | View, Job request 10177 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10176 | TPP | 0/1 | Bang Zheng | 3 years, 9 months ago 12 July 2022 21:49:35 UTC | View, Job request 10176 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10175 | TPP | 0/1 | Bang Zheng | 3 years, 9 months ago 12 July 2022 21:43:28 UTC | View, Job request 10175 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10172 | TPP | 0/1 | Bang Zheng | 3 years, 9 months ago 12 July 2022 16:45:43 UTC | View, Job request 10172 |
| Succeeded | Covid-19 related death over time | covid_mortality_over_time | 10168 | TPP | 9/9 | Linda Nab | 3 years, 9 months ago 12 July 2022 17:33:03 UTC | View, Job request 10168 |
| Succeeded | Covid-19 related death over time | covid_mortality_over_time | 10164 | TPP | 5/5 | Linda Nab | 3 years, 9 months ago 12 July 2022 12:58:48 UTC | View, Job request 10164 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10148 | TPP | 1/1 | John Tazare | 3 years, 10 months ago 11 July 2022 20:57:28 UTC | View, Job request 10148 |
| Failed | Coverage, effectiveness and safety of neutralising monoclonal antibodies or antivirals for non-hospitalised patients with COVID-19 | paxlovid_sotrovimab | 10145 | TPP | 0/1 | Bang Zheng | 3 years, 10 months ago 11 July 2022 17:54:58 UTC | View, Job request 10145 |
| Succeeded | Effectiveness of sotrovimab/molnupiravir use vs non-use | mab-av-non-user-main | 10144 | TPP | 5/5 | John Tazare | 3 years, 10 months ago 11 July 2022 17:36:48 UTC | View, Job request 10144 |